Literature DB >> 19213070

Percutaneous intervention for chronic total occlusion of the internal iliac artery for unrelenting buttock claudication.

Satjit Adlakha1, Mark Burket, Christopher Cooper.   

Abstract

Internal iliac artery stenosis or occlusion has been documented to cause hip pain, erectile dysfunction, and buttock claudication. Endovascular repair for patients with significant stenosis has been well documented, but chronic total occlusion revascularizations have not been reported in the literature. The reluctance to attempt percutaneous intervention may be in part due to the extensive collateralization that forms to this vessel, or fear of complications such as wire perforation in a vessel that has a tortuous route with multiple bifurcations. This report describes two cases of patients with unrelenting buttock claudication that completely resolved after percutaneous intervention of unilateral chronic total occlusions of the internal iliac artery. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19213070     DOI: 10.1002/ccd.21966

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Endovascular treatment of internal iliac artery stenosis in patients with buttock claudication.

Authors:  Jip F Prince; Maarten L J Smits; Joost A van Herwaarden; Mark J Arntz; Evert-Jan P A Vonken; Maurice A A J van den Bosch; Gert Jan de Borst
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

2.  Endovascular treatment of patients with bilateral internal iliac artery disease and buttock claudication.

Authors:  Mehmet Özkan; Burak Teymen
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

Review 3.  Internal Iliac Artery Stenosis: Diagnosis and How to Manage it in 2015.

Authors:  Guillaume Mahé; Adrien Kaladji; Alexis Le Faucheur; Vincent Jaquinandi
Journal:  Front Cardiovasc Med       Date:  2015-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.